Curaleaf Laboratories and Herdade das Barrocas (HDB) Announce Strategic Partnership to Reintroduce HDB Products to the UK Medical Cannabis Market
London, United Kingdom – 22nd June 2026 – Curaleaf Laboratories, one of the UK’s leading manufacturers and distributors of EU-GMP medical cannabis products and Herdade das Barrocas (HDB), a Portuguese cultivator known for its cannabis genetics and cultivation expertise, are pleased to announce a new manufacturing and supply partnership that will see HDB products reintroduced to healthcare […]
420 and the UK Medical Cannabis Sector: Beyond the Noise
Every year, 20th April brings a familiar wave of headlines, commentary and public discussion about cannabis. For many people, 420 remains a cultural reference point, shaped by symbolism, visibility, and a long-standing association with cannabis. That is the part most people see. The more important story in the UK is what sits behind the public […]
Curaleaf Laboratories Enters Strategic Partnership with ANTG to Manufacture and Distribute Medicinal Cannabis Products in the UK
London, UK – 12th November, 2025 – Curaleaf Laboratories, one of the UK’s leading providers of medicinal cannabis products, is pleased to announce a landmark partnership with Australian Natural Therapeutics Group (ANTG), one of Australia’s most respected producers of pharmaceutical-grade medicinal cannabis. Under this agreement, Curaleaf Laboratories will manufacture and distribute ANTG’s range of products […]